michel lazdunski
michel lazdunski
Professeur,Institute Molecular Pharmacology,CNRS,UCA,Nice-Sophia Antipolis
Dirección de correo verificada de ipmc.cnrs.fr
TítuloCitado porAño
Voltage-gated potassium channels (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
B Attali, KG Chandy, MH Giese, S Grissmer, GA Gutman, LY Jan, ...
IUPHAR/BPS Guide to Pharmacology CITE 2019 (4), 2019
2019
Inwardly rectifying potassium channels (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
JP Adelman, DE Clapham, H Hibino, A Inanobe, LY Jan, A Karschin, ...
IUPHAR/BPS Guide to Pharmacology CITE 2019 (4), 2019
2019
People's corner: Pedro Brugada & Peter Schwartz share award
K Alto, A Carpentier, G de Gaetano, F Gros, M Haissaguerre, M Lazdunski, ...
EUROPEAN HEART JOURNAL 40 (32), 2670-2670, 2019
2019
Pedro Brugada and Peter Schwartz share the Lefoulon-Delalande Foundation Scientific Prize 2019.
K Alto, A Carpentier, G de Gaetano, F Gros, M Haissaguerre, M Lazdunski, ...
European heart journal 40 (32), 2670, 2019
2019
Therapy for promoting cell growth
MMJ Lazdunski, CL Heurteaux, D Picard
US Patent App. 16/242,654, 2019
2019
Chemical Synthesis, Proper Folding, Nav Channel Selectivity Profile and Analgesic Properties of the Spider Peptide Phlotoxin 1
S Nicolas, C Zoukimian, F Bosmans, J Montnach, S Diochot, E Cuypers, ...
Toxins 11 (6), 367, 2019
12019
Method of manufacturing switching element
Y Murakami, Y Urakami, Y Yamashita
US Patent App. 10/243,035, 2019
12019
Therapy for promoting cell growth
MMJ Lazdunski, CL Heurteaux, D Picard
US Patent App. 10/188,688, 2019
132019
The Traditional Chinese Medicine MLC901 inhibits inflammation processes after focal cerebral ischemia
C Widmann, C Gandin, A Petit-Paitel, M Lazdunski, C Heurteaux
Scientific reports 8 (1), 1-15, 2018
62018
Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin
L Poupon, S Lamoine, V Pereira, DA Barriere, S Lolignier, F Giraudet, ...
Neuropharmacology 140, 43-61, 2018
102018
Method for determining the glycosylation of an antibody
D Jaga, H Mokrane, S Martinez, M Fink
US Patent 9,880,176, 2018
2018
Acute and long-term cardioprotective effects of the Traditional Chinese Medicine MLC901 against myocardial ischemia-reperfusion injury in mice
A Vincent, A Covinhes, C Barrère, L Gallot, S Thoumala, C Piot, ...
Scientific reports 7 (1), 14701, 2017
32017
Recombinant tandem of pore-domains in a Weakly Inward rectifying K+ channel 2 (TWIK2) forms active lysosomal channels
N Bobak, S Feliciangeli, CC Chen, IB Soussia, S Bittner, S Pagnotta, ...
Scientific reports 7 (1), 649, 2017
52017
MLC901 issued from traditional Chinese medicine favors angiogenesis and associated recovery after ischemic stroke
C Gandin, C Widmann, M Lazdunski, C Heurteaux
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 37, 111-111, 2017
2017
Cardioprotective effects of chinese medicine NurAiD™ II
A Vincent, S Thoumala, A Covinhes, C Barrere, L Gallot, C Piot, ...
Archives of Cardiovascular Diseases Supplements 9 (2), 156-157, 2017
2017
Use of riluzole for treating or preventing the adverse effects of antineoplastic agents
J Busserolles, A Alloui, M Lazdunski, A Eschalier
US Patent 9,511,045, 2016
12016
Use of K2P potassium channel activators as antalgics
A Eschalier, J Busserolles, A Alloui, M Lazdunski
US Patent 9,448,242, 2016
2016
Therapy for promoting cell growth
MMJ Lazdunski, CL Heurteaux, D Picard
US Patent App. 15/018,505, 2016
2016
Therapy for promoting cell growth
MMJ Lazdunski, CL Heurteaux, D Picard
US Patent 9,289,459, 2016
52016
MLC901 favors angiogenesis and associated recovery after ischemic stroke
C Heurteaux, C Gandin, C Widmann, M Lazdunski
CEREBROVASCULAR DISEASES 41, 259-259, 2016
2016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20